Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Automated External Defibrillator Market, by Product
1.4.2 North America Automated External Defibrillator Market, by End-use
1.4.3 North America Automated External Defibrillator Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies Deployed in Automated External Defibrillator Market
Chapter 5. North America Automated External Defibrillator Market by Product
5.1 North America Fully-automated Market by Country
5.2 North America Semi-automated Market by Country
Chapter 6. North America Automated External Defibrillator Market by End-use
6.1 North America Hospital Market by Country
6.2 North America Pre Hospital Market by Country
6.3 North America Public Access Market by Country
6.4 North America Homecare Market by Country
6.5 North America Others Market by Country
Chapter 7. North America Automated External Defibrillator Market by Country
7.1 US Automated External Defibrillator Market
7.1.1 US Automated External Defibrillator Market by Product
7.1.2 US Automated External Defibrillator Market by End-use
7.2 Canada Automated External Defibrillator Market
7.2.1 Canada Automated External Defibrillator Market by Product
7.2.2 Canada Automated External Defibrillator Market by End-use
7.3 Mexico Automated External Defibrillator Market
7.3.1 Mexico Automated External Defibrillator Market by Product
7.3.2 Mexico Automated External Defibrillator Market by End-use
7.4 Rest of North America Automated External Defibrillator Market
7.4.1 Rest of North America Automated External Defibrillator Market by Product
7.4.2 Rest of North America Automated External Defibrillator Market by End-use
Chapter 8. Company Profiles
8.1 Nihon Kohden Corporation (Defibtech LLC)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Product Category and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.6 SWOT Analysis
8.2 Koninklijke Philips N.V.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Trials / Approvals:
8.2.6 SWOT Analysis
8.3 Bpl Medical Technologies Private Limited
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 Corpuls (Nordic Capital)
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 Progetti SRL
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 Stryker Corporation (HeartSine Technologies, Ltd.)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.6 SWOT Analysis
8.7 CU Medical Systems, Inc.
8.7.1 Company Overview
8.7.2 SWOT Analysis
8.8 Silverline Meditech Pvt. Ltd.
8.8.1 Company Overview
8.9 AMI Italia S.r.l.
8.9.1 Company Overview
8.10. Medtronic PLC
8.10.1 Company overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
8.10.5.3 Trials / Approvals:
8.10.6 SWOT Analysis
Unique Offerings 